These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 26228280

  • 21. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.
    Hiraoka A, Hirooka M, Koizumi Y, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Michitaka K, Horiike N, Yamashita Y, Hiasa Y, Matsuura B, Onji M.
    Oncol Rep; 2010 Feb; 23(2):493-7. PubMed ID: 20043112
    [Abstract] [Full Text] [Related]

  • 22. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.
    Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, Ueshima K, Shiozaki H.
    AJR Am J Roentgenol; 2008 Jun; 190(6):W335-41. PubMed ID: 18492875
    [Abstract] [Full Text] [Related]

  • 23. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY.
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [Abstract] [Full Text] [Related]

  • 24. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ, Won HJ, Kim KW, Shin YM, Kim PN.
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [Abstract] [Full Text] [Related]

  • 25. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography.
    Liu FY, Yu XL, Liang P, Cheng ZG, Han ZY, Dong BW, Zhang XH.
    Eur J Radiol; 2012 Jul; 81(7):1455-9. PubMed ID: 21477961
    [Abstract] [Full Text] [Related]

  • 26. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1-3 cm): value of fusion imaging with conventional US and CT/MR images.
    Lee MW, Rhim H, Cha DI, Kim YJ, Lim HK.
    J Vasc Interv Radiol; 2013 Jul; 24(7):958-65. PubMed ID: 23796082
    [Abstract] [Full Text] [Related]

  • 27. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW, Rhim H, Cha DI, Kim YJ, Choi D, Kim YS, Lim HK.
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [Abstract] [Full Text] [Related]

  • 28. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
    Minami T, Minami Y, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Inoue T, Hagiwara S, Ueshima K, Nishida N, Kudo M.
    Oncology; 2014 Jun; 87 Suppl 1():55-62. PubMed ID: 25427734
    [Abstract] [Full Text] [Related]

  • 29. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.
    Kisaka Y, Hirooka M, Koizumi Y, Abe M, Matsuura B, Hiasa Y, Onji M.
    J Clin Ultrasound; 2010 Jun; 38(3):138-44. PubMed ID: 20014137
    [Abstract] [Full Text] [Related]

  • 30. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images.
    Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hatanaka K, Ueda T, Hagiwara H, Kitai S, Ueshima K, Fukunaga T, Shiozaki H.
    Oncology; 2007 Jun; 72 Suppl 1():111-6. PubMed ID: 18087191
    [Abstract] [Full Text] [Related]

  • 31. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
    Giorgio A, Tarantino L, de Stefano G, Scala V, Liorre G, Scarano F, Perrotta A, Farella N, Aloisio V, Mariniello N, Coppola C, Francica G, Ferraioli G.
    AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?
    Zhou P, Kudo M, Minami Y, Chung H, Inoue T, Fukunaga T, Maekawa K.
    Oncology; 2007 Aug; 72 Suppl 1():92-7. PubMed ID: 18087188
    [Abstract] [Full Text] [Related]

  • 35. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
    Yasumoto T, Murakami T, Katsumoto Y, Hashimoto T, Noda S, Murata K, Kinuta M, Nakamura H.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
    [Abstract] [Full Text] [Related]

  • 36. Abdominal virtual ultrasonographic images reconstructed by multi-detector row helical computed tomography.
    Hirooka M, Iuchi H, Kurose K, Kumagi T, Horiike N, Onji M.
    Eur J Radiol; 2005 Feb; 53(2):312-7. PubMed ID: 15664297
    [Abstract] [Full Text] [Related]

  • 37. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH, Yang W, Yan K, Dai Y, Wu W, Fan ZH, Callstrom MR, Charboneau JW.
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH, Lim HK, Lim S, Kang TW, Song KD, Choi SY, Rhim H, Lee MW.
    Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
    [Abstract] [Full Text] [Related]

  • 40. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Lee LH, Hwang JI, Cheng YC, Wu CY, Lee SW, Yang SS, Yeh HZ, Chang CS, Lee TY.
    PLoS One; 2017 Mar; 12(1):e0169655. PubMed ID: 28068369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.